Similar articles

• Drugs for cardiac arrhythmias: new warning.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1989 May 19;31(792):48. Med Lett Drugs Ther. 1989. PMID: 2497313 No abstract available.
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

  Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ, et al. Akhtar M, et al. Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123. Circulation. 1990. PMID: 1689621 Review. No abstract available.
• Clinical experience of encainide (MJ 9067): a new anti-arrhythmic drug.

  Kesteloot H, Stroobandt R. Kesteloot H, et al. Eur J Clin Pharmacol. 1979 Nov;16(5):323-6. doi: 10.1007/BF00605629. Eur J Clin Pharmacol. 1979. PMID: 93050 Clinical Trial.
• [Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole].

  Dumoulin P, Jaillon P, Kher A, Poirier JM, Cheymol G, Valty J, Flammang D, Coumel P, Medvedowsky JL, Barnay C, et al. Dumoulin P, et al. Arch Mal Coeur Vaiss. 1985 Oct;78 Spec No:105-9. Arch Mal Coeur Vaiss. 1985. PMID: 2420299 Clinical Trial. French.
• The clinical use of class IC antiarrhythmic drugs.

  Abi Samra F. Abi Samra F. J La State Med Soc. 1989 May;141(5):27-31. J La State Med Soc. 1989. PMID: 2499646 Review.